144 related articles for article (PubMed ID: 25463884)
1. Value of prostate gland volume measurement by transrectal US in prediction of the severity of lower urinary tract symptoms.
Tatar IG; Ergun O; Celtikci P; Birgi E; Hekimoglu B
Med Ultrason; 2014 Dec; 16(4):315-8. PubMed ID: 25463884
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of the international prostate symptom score for positive prostate needle biopsy in the low-intermediate prostate-specific antigen range.
Kefi A; Irer B; Ozdemir I; Tuna B; Goktay Y; Yorukoğlu K; Esen A
Urol Int; 2005; 75(3):222-6. PubMed ID: 16215309
[TBL] [Abstract][Full Text] [Related]
3. [Does antibiotherapy prevent unnecessary prostate biopsies in patients with high PSA values?].
Faydaci G; Eryildirim B; Tarhan F; Goktas C; Tosun C; Kuyumcuoglu U
Actas Urol Esp; 2012 Apr; 36(4):234-8. PubMed ID: 22258038
[TBL] [Abstract][Full Text] [Related]
4. Presence and severity of lower urinary tract symptoms are inversely correlated with the risk of prostate cancer on prostate biopsy.
Cicione A; Cormio L; Cantiello F; Palumbo IM; DE Nunzio C; Lima E; Ucciero G; Carrieri G; Damiano R
Minerva Urol Nefrol; 2017 Oct; 69(5):486-492. PubMed ID: 28124868
[TBL] [Abstract][Full Text] [Related]
5. Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms.
Vesely S; Knutson T; Damber JE; Dicuio M; Dahlstrand C
Scand J Urol Nephrol; 2003; 37(4):322-8. PubMed ID: 12944191
[TBL] [Abstract][Full Text] [Related]
6. Is there any association between the severity of lower urinary tract symptoms and the risk of biopsy-detectable prostate cancer in patients with PSA level below 20 ng/ml in multi-core prostate biopsy?
Oh JJ; Jeong SJ; Jeong CW; Byun SS; Hong SK; Choe G; Lee SE
Prostate; 2013 Jan; 73(1):42-7. PubMed ID: 22585359
[TBL] [Abstract][Full Text] [Related]
7. Prospective comparison of the novel visual prostate symptom score (VPSS) versus the international prostate symptom score (IPSS), and assessment of patient pain perception with regard to transrectal ultrasound guided prostate biopsy.
Els M; Heyns C; van der Merwe A; Zarrabi A
Int Braz J Urol; 2019; 45(1):137-144. PubMed ID: 30620160
[TBL] [Abstract][Full Text] [Related]
8. Prediction of prostate cancer in extended-field biopsies of the prostate.
Winkler MH; Kulinskaya E; Gillatt DA
BJU Int; 2004 Mar; 93(4):516-21. PubMed ID: 15008721
[TBL] [Abstract][Full Text] [Related]
9. Absence of lower urinary tract symptoms is an independent predictor for cancer at prostate biopsy, but prostate-specific antigen is not: results from a prospective series of 569 patients.
Porter CR; Latchamsetty KC; Coogan CL; Kim J
Clin Prostate Cancer; 2005 Jun; 4(1):50-4. PubMed ID: 15992462
[TBL] [Abstract][Full Text] [Related]
10. Impact of Androgen Deprivation Therapy on Volume Reduction and Lower Urinary Tract Symptoms in Patients with Prostate Cancer.
Washino S; Hirai M; Saito K; Kobayashi Y; Arai Y; Miyagawa T
Low Urin Tract Symptoms; 2018 Jan; 10(1):57-63. PubMed ID: 27943566
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of peripheral zone thickness in men with lower urinary tract symptoms/benign prostatic hyperplasia.
Kwon JK; Han JH; Choi HC; Kang DH; Lee JY; Kim JH; Oh CK; Choi YD; Cho KS
BJU Int; 2016 Feb; 117(2):316-22. PubMed ID: 25807886
[TBL] [Abstract][Full Text] [Related]
12. Comparison of transrectal ultrasound-guided biopsy of the prostate and transurethral resection of the prostate for detection of prostate cancer in patients with moderate lower urinary tract symptoms.
Chen SS; Chiu LP; Chen KK
J Chin Med Assoc; 2010 Nov; 73(11):568-72. PubMed ID: 21093824
[TBL] [Abstract][Full Text] [Related]
13. Cumulative probability of prostate cancer detection using the international prostate symptom score in a prostate-specific antigen-based population screening program in Japan.
Kitagawa Y; Urata S; Narimoto K; Nakagawa T; Izumi K; Kadono Y; Konaka H; Mizokami A; Namiki M
Asian Pac J Cancer Prev; 2014; 15(17):7079-83. PubMed ID: 25227794
[TBL] [Abstract][Full Text] [Related]
14. Hypovitaminosis D is associated with lower urinary tract symptoms and benign prostate hyperplasia in type 2 diabetes.
Caretta N; Vigili de Kreutzenberg S; Valente U; Guarneri G; Pizzol D; Ferlin A; Avogaro A; Foresta C
Andrology; 2015 Nov; 3(6):1062-7. PubMed ID: 26339755
[TBL] [Abstract][Full Text] [Related]
15. Is increased prostatic urethral angle related to lower urinary tract symptoms in males with benign prostatic hyperplasia/lower urinary tract symptoms?
Park YJ; Bae KH; Jin BS; Jung HJ; Park JS
Korean J Urol; 2012 Jun; 53(6):410-3. PubMed ID: 22741050
[TBL] [Abstract][Full Text] [Related]
16. Correlation between the total volume, transitional zone volume of the prostate, transitional prostate zone index and lower urinary tract symptoms (LUTS).
Franciosi M; Koff WJ; Rhoden EL
Int Urol Nephrol; 2007; 39(3):871-7. PubMed ID: 17203347
[TBL] [Abstract][Full Text] [Related]
17. Serum prostate-specific antigen as a predictor of prostate volume and lower urinary tract symptoms in a community-based cohort: a large-scale Korean screening study.
Park DS; Oh JJ; Hong JY; Hong YK; Choi DK; Gong IH; Hwang JH; Kwon SW
Asian J Androl; 2013 Mar; 15(2):249-53. PubMed ID: 23353717
[TBL] [Abstract][Full Text] [Related]
18. Correlation between international prostate symptom score and uroflowmetry in patients with benign prostatic hyperplasia.
Oranusi CK; Nwofor AE; Mbonu O
Niger J Clin Pract; 2017 Apr; 20(4):454-458. PubMed ID: 28406126
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P
Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
[TBL] [Abstract][Full Text] [Related]
20. Clinical usefulness of free PSA in early detection of prostate cancer.
Luboldt HJ; Swoboda A; Börgermann C; Fornara P; Rübben H;
Onkologie; 2001 Feb; 24(1):33-7. PubMed ID: 11441278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
